Skip to content

Clinical trials

Phase 2 Gout trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gout Phase: Phase 2 Country / region: United States Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20071
20082
20093
20106
20114
20121
20131
20144
20153
20161
20172
20192
20201
20212
20223
20231
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Recruiting3
Active, not recruiting2
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences5
Ardea Biosciences, Inc.4
BioCryst Pharmaceuticals4
Arthrosi Therapeutics3
Takeda3
Allena Pharmaceuticals2
Nuon Therapeutics, Inc.2
Ampel BioSolutions, LLC1
AstraZeneca1
Atom Therapeutics Co., Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gout43
Hyperuricemia23
Arthritis, Gouty4
Arthritis2
Joint Diseases2
Renal Insufficiency2
Renal Insufficiency, Chronic2

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.